Skip to content
10-Q

Quarterly Report

THE TEARDROPPERS, INC.

0001683168-21-005313

← back to feed
Filed
Nov 8, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 8, 2021 45.92M sh
Current Liabilities Q3 2021 · Sep 30, 2021 $2.21M
Current Liabilities Q3 2021 · Dec 31, 2020 $1.87M
Total Liabilities Q3 2021 · Sep 30, 2021 $2.28M
Total Liabilities Q3 2021 · Dec 31, 2020 $2M
Current Assets Q3 2021 · Sep 30, 2021 $137.48K
Current Assets Q3 2021 · Dec 31, 2020 $101.93K
Total Assets Q3 2021 · Sep 30, 2021 $326.21K
Total Assets Q3 2021 · Dec 31, 2020 $373.82K
Shares Diluted Q3 2021 · Sep 30, 2020 45.92M sh
Shares Diluted Q3 2021 · Sep 30, 2020 45.92M sh
Capex Q3 2021 · Sep 30, 2020 $69K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$170.43K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$1.52M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$1.43M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$1.34M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$1.17M
Sga Expense Q3 2021 · Sep 30, 2020 $38.46K
Sga Expense Q3 2021 · Sep 30, 2020 $158.09K
Net Income Q3 2021 · Sep 30, 2020 −$87.35K
Net Income Q3 2021 · Sep 30, 2020 −$346.18K
Operating Income Q3 2021 · Sep 30, 2020 −$70.19K
Operating Income Q3 2021 · Sep 30, 2020 −$298.12K
Revenue Q3 2021 · Sep 30, 2020 $19.28K
Revenue Q3 2021 · Sep 30, 2020 $51.83K